Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Enliven Therapeutics, Inc. | StockGist | StockGist

Companies
ELVN
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings ELVNSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Enliven Therapeutics, Inc.

Filed Feb 17, 2026

Accepted Feb 16, 2026, 7:00 PM ET

CIK 0001672619

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

Shares Owned

59,347,317

Reporting Person

Enliven Therapeutics, Inc.

Person Type

IA

CUSIP: 29337E102

Key Facts

Shares Owned

59,347,317

Recent Filings

Enliven Therapeutics, Inc.1 months ago

Enliven Therapeutics, Inc.1 months ago

Enliven Therapeutics, Inc.2 months ago

Enliven Therapeutics, Inc.3 months ago

Enliven Therapeutics, Inc.4 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice